Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
JNJ [NYSE]
Johnson & Johnson
IndexDJIA S&P500 P/E19.84 EPS (ttm)5.41 Insider Own0.02% Shs Outstand2.82B Perf Week2.25%
Market Cap302.76B Forward P/E16.91 EPS next Y6.35 Insider Trans-1.57% Shs Float2.82B Perf Month5.23%
Income15.55B PEG2.80 EPS next Q1.43 Inst Own67.20% Short Float0.79% Perf Quarter5.12%
Sales73.54B P/S4.12 EPS this Y24.60% Inst Trans-0.33% Short Ratio3.61 Perf Half Y16.28%
Book/sh27.61 P/B3.89 EPS next Y7.14% ROA11.80% Target Price109.13 Perf Year23.93%
Cash/sh11.21 P/C9.57 EPS next 5Y7.10% ROE20.80% 52W Range83.15 - 106.63 Perf YTD19.68%
Dividend2.80 P/FCF36.64 EPS past 5Y1.00% ROI15.00% 52W High0.68% Beta0.59
Dividend %2.61% Quick Ratio2.10 Sales past 5Y2.30% Gross Margin69.00% 52W Low29.10% ATR0.99
Employees128100 Current Ratio2.50 Sales Q/Q9.10% Oper. Margin28.40% RSI (14)75.31 Volatility1.00% 0.82%
OptionableYes Debt/Eq0.22 EPS Q/Q14.40% Profit Margin21.20% Rel Volume1.07 Prev Close106.19
ShortableYes LT Debt/Eq0.17 EarningsOct 13 BMO Payout48.60% Avg Volume6.20M Price107.35
Recom2.30 SMA203.23% SMA504.84% SMA20010.63% Volume6,627,442 Change1.09%
16-Jul-14Reiterated Deutsche Bank Hold $102 → $107
17-Apr-14Reiterated Argus Buy $104 → $116
16-Apr-14Reiterated RBC Capital Mkts Outperform $104 → $106
10-Jan-14Downgrade Barclays Overweight → Equal Weight $99
07-Jan-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
16-Dec-13Reiterated Deutsche Bank Hold $93 → $95
18-Jul-13Reiterated Argus Buy $96 → $104
17-Jul-13Reiterated Barclays Overweight $95 → $99
17-Jul-13Downgrade Deutsche Bank Buy → Hold $92 → $93
18-Apr-13Reiterated Argus Buy $80 → $96
15-Apr-13Reiterated Barclays Overweight $85 → $95
12-Apr-13Reiterated Deutsche Bank Buy $82 → $87
26-Mar-13Reiterated UBS Buy $81 → $87
11-Jan-13Reiterated UBS Buy $76 → $78
04-Jan-13Upgrade Deutsche Bank Hold → Buy $75 → $82
20-Nov-12Initiated Stifel Nicolaus Hold
18-Jul-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
18-Apr-12Reiterated UBS Buy $71 → $70
12-Dec-11Reiterated UBS Buy $72 → $69
17-Oct-11Reiterated UBS Buy $74 → $72
18-Sep-14 05:24PM  Today's Market Thorns, Roses and All Time Highs... Yahoo Finance Blogs
04:02AM  Corporate bond ratings do not discern risk at Financial Times
12:01AM  Fish-Choking Balls Have States Limiting Cosmetic Contents Bloomberg
12:01AM  Fish-Choking Balls Have States Limiting Cosmetic Contents at Bloomberg
16-Sep-14 10:02AM  IBM Touts Watson to Back Office Amid Cloud Service Push at Bloomberg
09:52AM  AstraZeneca and Eli Lilly to unite for Alzheimer's drug challenge at Financial Times
08:00AM  The Keys In This Market: Income & Growth at Forbes
15-Sep-14 08:25PM  Lawyer grills DePuy executive over safety studies for Pinnacle hips Reuters
09:30AM  A Fabulous Pharma ETF ETF Trends
14-Sep-14 04:34PM  3 Companies Investing In Stem Cell Research Benzinga
12-Sep-14 06:09PM  Adapting Listerine to a Global Market at New York Times
04:30PM  Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Exxon Mobil Corporation (XOM) Lags at TheStreet
02:41PM  Addressing Disengagement And Depression Lifts Workers at Investor's Business Daily
10:30AM  Insider Trading Alert - JNJ, EL And GPI Traded By Insiders at TheStreet
11-Sep-14 05:41PM  Medivation Eyes Blockbuster As Cancer Drug Gets An OK at Investor's Business Daily
12:15PM  J&J Plans for the Future by Trimming Pension Benefits for New Hires at The Wall Street Journal
10-Sep-14 03:37PM  Medivation Prostate Cancer Drug Secures Expanded FDA Label at TheStreet
08:50AM  Top UBS Dividend Ruler Stocks Continue to Increase Shareholder Payouts at 24/7 Wall St.
09-Sep-14 12:08PM  [video] As Life Expectancies Rise, Death Care Stocks Offer Opportunities at TheStreet
06:30AM  Johnson & Johnson Should Ignore Those Breakup Calls at TheStreet
08-Sep-14 04:25PM  Glaxo Announces EU Nod for Single-Pill HIV Drug Triumeq Zacks
08:08AM  Pharmalot, Pharmalittle: We're Reading About Ebola, Glaxo, J&J and Much More!! at The Wall Street Journal
08:08AM  The Zacks Analyst Blog Highlights: Intel, Advanced Micro Devices, Johnson & Johnson, Bayer and McDonald's Zacks
07-Sep-14 01:00PM  Experimental Ebola vaccine protects monkeys for 10 months Reuters
05-Sep-14 05:40PM  Stock Market Video Analysis 9/5/14 Yahoo Finance Blogs
02:14PM  J&J Ordered to Pay $3.27 Million Over Mesh Implant at Bloomberg
02:12PM  Dow 30 Stock Roundup: MSFT Widens Surface Pro 3 Availability, MCD Shutters Several Russia Units Zacks
11:21AM  [video] Morgan Stanley Replaced by Citigroup on Evercore's 'Marquee' List at TheStreet
08:37AM  Will This Ratings Initiation Help Johnson & Johnson (JNJ) Stock Today? at TheStreet
04-Sep-14 06:18PM  J&J Aware of Hip Poisoning Worry in 2001, Lawyer Says at Bloomberg
03:25PM  [video] Accelerating Ebola vaccine at CNBC
02:37PM  J&J Ebola Vaccine Gets Funding, Development to Pick Pace Zacks
01:23PM  Must-know: The US economy grew 4.2% in the second quarter Market Realist
11:00AM  Dow Today: Johnson & Johnson (JNJ) Higher at TheStreet
09:59AM  Will Johnson & Johnson (JNJ) Stock Be Helped By Fast Track Ebola Vaccine? at TheStreet
01:16AM  J&J to Accelerate Ebola Vaccine Development at Bloomberg
12:01AM  [$$] Johnson & Johnson to Quicken Development of Ebola Vaccine at The Wall Street Journal
12:01AM  Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate Vaccine Program in Collaboration With the US National Institutes of Health (NIH) and Provide Humanitarian Relief Aid PR Newswire
03-Sep-14 04:29PM  Sharper Focus Pays Dividends At Johnson & Johnson at Investor's Business Daily
04:22PM  Drug M&A Boom Driven By Long-Term Trends: PwC at Investor's Business Daily
04:10PM  Bayer Discloses Encouraging Data on Anticoagulant Xarelto Zacks
03:11PM  J&J Unit Ran Amok Marketing Pinnacle Hips, Jury Told at Bloomberg
07:45AM  Johnson & Johnson to Participate in 2014 Morgan Stanley Health Care Conference PR Newswire
02-Sep-14 05:30PM  Bayer/Johnson & Johnson to Expand Xarelto Label Further Zacks
05:05AM  China Targeting Foreign Companies, American Chamber Says Bloomberg
01-Sep-14 04:30PM  Dow Today: Johnson & Johnson (JNJ) Leads The Day Higher, McDonald's (MCD) Lags at TheStreet
29-Aug-14 04:41PM  [video] The Top Ten Stocks for Aug. 29 at Bloomberg
01:22PM  Why J&J Wants to Divest Medical Devices Business StockTwits
12:31PM  [video] U.S. Stocks on Track to Head Into Labor Day Weekend With Gains at TheStreet
12:31PM  [video] U.S. Stocks on Track to Head into Labor Day Weekend with Gains at TheStreet
10:25AM  US STOCKS-Wall St edges down but on track for 4th week of gains Reuters
10:21AM  [$$] J&J, Bayer Aim to Expand Xarelto's Uses at The Wall Street Journal
09:13AM  Bank Of America Remains Optimistic On Johnson & Johnson Benzinga
08:47AM  Morgan Stanley Sees More Focused Device Strategy Continue For Johnson & Johnson Benzinga
07:47AM  Will Johnson & Johnson (JNJ) Stock Benefit From Cordis Unit Sale? at TheStreet
07:26AM  US STOCKS-Futures up, indexes on track for 4th week of gains Reuters
28-Aug-14 08:27PM  Johnson & Johnson to seek buyer for medical device maker unit -WSJ Reuters
07:52PM  Johnson & Johnson Said Exploring Sale of Cordis Devices Business at Bloomberg
03:49PM  Why Johnson & Johnson (JNJ) Stock Is Declining Today at TheStreet
01:18PM  Focus On A Big-Picture Purpose To Get Top Results at Investor's Business Daily
08:17AM  FDA says Johnson & Johnson recalls some jaw implants Reuters
27-Aug-14 12:01AM  You Sure You Belong Here? Companies Hone Message to Sift Applicants Bloomberg
12:01AM  J&J Leads Companies Honing Message to Sift Job Applicants Bloomberg
12:01AM  J&J Leads Companies Honing Message to Sift Job Applicants at Bloomberg
26-Aug-14 08:26AM  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Pfizer, Johnson & Johnson, Allergan and EA Sports Zacks
25-Aug-14 04:03PM  The 4 Companies Teaming Up For A New Tool To Fight Cancer Benzinga
03:01PM  The Longer Term View on Johnson & Johnson Yahoo Finance Blogs
08:37AM  Vivus acquires patent rights to Qsymia ingredient AP
23-Aug-14 05:56PM  5 P&G executives in position to become CEO at USA TODAY
22-Aug-14 05:25PM  Omnicom Offers Steady Profit Growth, Rising Dividend at Investor's Business Daily
04:55PM  Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod Zacks
04:55PM  Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf at TheStreet
02:14PM  Gilead Sciences: Don't You Forget About Me at Barrons.com
21-Aug-14 05:02PM  Apple Stock Held By Institutional Investors Rises at Investor's Business Daily
04:07PM  FDA Grants New Indication For Pfizer, Bristol-Myers Squibb Drug at Forbes
10:59AM  Dow back above 17,000; S&P 500 rises to record at CNBC
10:09AM  Must-See Charts: Still Time to Buy These 5 Stocks at TheStreet
07:45AM  The Zacks Analyst Blog Highlights: Johnson & Johnson, Tekmira Pharmaceuticals, Gilead Sciences, Allergan and Supernus Pharmaceuticals Zacks
02:00AM  Illumina Partners With Big Pharma To Create New Genetic Tests For Cancer at Forbes
20-Aug-14 03:27PM  Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy Zacks
19-Aug-14 06:27PM  This stock may be hazardous to your financial health Talking Numbers
14-Aug-14 06:04PM  Scientists racing to test Ebola vaccines in humans AP
05:37PM  Scientists racing to test Ebola vaccines in humans AP
01:57PM  Robert Wood Johnson's New Industry Made Surgery Safer at Investor's Business Daily
13-Aug-14 02:42PM  Vertex to end sales of hepatitis C drug Incivek Reuters
12-Aug-14 04:53PM  Earnings Season Is The Right Prescription For Health Care ETFs Benzinga
02:16PM  [video] Global risk playbook at CNBC
12:25PM  WHO backs use of experimental Ebola drugs in West Africa epidemic Reuters
10:48AM  Intercept Pharma Soars On Liver-Disease Drug Data at Investor's Business Daily
09:49AM  Entia Biosciences' Supplements Could Prevent Dementia Accesswire
07:45AM  WHO backs use of experimental Ebola drugs in West Africa outbreak Reuters
11-Aug-14 03:12PM  Colgate Total Ingredient Linked to Hormones, Cancer Spotlights FDA Process Bloomberg
02:56PM  Colgate Total Ingredient Linked to Hormones, Cancer Spotlights FDA Process Bloomberg
12:01AM  Colgate Total Ingredient Linked to Hormones, Cancer Spotlights FDA Process Bloomberg
12:01AM  Cancer-Linked Colgate Total Ingredient Suggests Flaws in FDA Approval Process Bloomberg
12:01AM  Cancer-Linked Colgate Chemical Detailed in Studies FDA Withheld Bloomberg
12:01AM  Brush With Cancer: Millions Put Troubling Chemical in Their Mouths Every Morning Bloomberg
08-Aug-14 01:04PM  JOHNSON & JOHNSON Financials EDGAR Online Financials
11:55AM  Medivation Cancer Drug Fuels Beat, Swings To Profit at Investor's Business Daily
11:15AM  [video] Inside Johnson & Johnson (08/05) at Bloomberg
Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women's health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON'S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CULLEN JAMESDirectorSep 10Sale104.122,446254,6721,489Sep 11 02:19 PM
Caruso Dominic JVP, Finance; CFOAug 21Option Exercise66.1830,0001,985,40091,600Aug 25 04:35 PM
Caruso Dominic JVP, Finance; CFOAug 21Sale104.3030,0003,129,06961,600Aug 25 04:35 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Option Exercise66.1822,0001,455,960112,294May 06 06:10 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Sale100.0522,0002,201,10090,294May 06 06:10 PM
JOHNSON & JOHNSON10% OwnerMay 01Option Exercise5.1672,690375,0801,773,730May 05 02:19 PM
COSGROVE STEPHEN JCorporate ControllerApr 25Option Exercise66.181,51099,93291,293Apr 28 05:03 PM
Fasolo PeterVP, Global Human ResourcesMar 14Sale93.156,824635,64015,647Mar 17 06:10 PM
Fasolo PeterVP, Global Human ResourcesMar 04Option Exercise62.6644,8612,811,19243,571Mar 05 06:18 PM
Ullmann Michael HVP, General CounselJan 10Option Exercise0.009,265065,448Jan 14 06:15 PM
Stoffels PaulusChief Scientific OfficerJan 10Option Exercise0.0018,690035,603Jan 14 06:03 PM
Gorsky AlexChairman, CEOJan 10Option Exercise0.0012,058081,579Jan 14 06:01 PM
Fasolo PeterVP, Worldwide Human ResourcesJan 10Option Exercise0.002,58809,310Jan 14 06:00 PM
COSGROVE STEPHEN JCorporate ControllerJan 10Option Exercise0.002,645090,804Jan 14 05:58 PM
Caruso Dominic JVP, Finance; CFOJan 10Option Exercise0.0012,121065,656Jan 14 05:56 PM
Ullmann Michael HVP, General CounselDec 13Option Exercise53.931,85099,77157,277Dec 16 06:18 PM
Fasolo PeterVP, Worldwide Human ResourcesNov 01Option Exercise0.008,620010,595Nov 05 10:58 AM
MULLIN LEO FDirectorOct 16Option Exercise53.937,600409,86830,752Oct 18 02:30 PM